Reaction

Blood Alkaline Phosphatase Decreased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 941 reports · 16 co-occurring drugs

As of the last recalculation, Blood Alkaline Phosphatase Decreased appears in 941 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is ASFOTASE ALFA (PRR 269.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Asfotase Alfa108269.3272.2
Sodium Bicarbonate3231.531.5
Sodium Bicarbonate Injection,3231.531.5
Fingolimod Hcl6517.817.8
Tolvaptan1116.916.9
Calcitriol Capsules 0.25 Mcg1415.715.7
Calcitriol Capsules 0.5 Mcg1415.715.7
Calcitriol1415.515.5
Entecavir815.315.3
Goserelin813.313.3
Denosumab9912.012.0
Eculizumab2510.410.4
Polatuzumab Vedotin49.19.1
Somatropin175.25.2
Romosozumab-Aqqg34.94.9
Adapalene30.40.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.